Moxifloxacin drug data and news

---

European govts give $14 mln to find new TB drugs  07 Mar 2006
The TB Alliance currently has 10 compounds in development and recently launched a partnership with Germany's Bayer to test an approved antibiotic, moxifloxacin ... - Reuters South Africa,

Antibiotic Tequin risky to diabetes patients  Mar 5, 2006
Along with gatifloxacin, cephalosporin, levofloxacin, moxifloxacin, or ciprofloxacin were also studied, but no risk was found to be with these antibiotics. ... - Food Consumer,

Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults  Mar 1, 2006
...treatment with a macrolide, a second-generation cephalosporin, or a respiratory fluoroquinolone (gatifloxacin, levofloxacin, moxifloxacin, or ciprofloxacin). ... - New England Journal of Medicine (subscription),

A Reduction In Tuberculosis Incidence, Prevalence And Death Rate ...  Mar 4, 2006
Finally, in animal studies, moxifloxacin, a drug with a long half-life that has potent bactericidal and sterilizing powers, has produced a stable cure, without ... - Medical News Today (press release),

Tequin Linked to High Risk of Dangerous Glucose Changes  Mar 1, 2006
Antibiotics used by the cases and controls included Tequin, Levaquin (levofloxacin), Avelox (moxifloxacin), Cipro (ciprofloxacin), cephalosporins and ... - MedPage Today,

Clostridium difficile: Old Scourge Becomes Far Worse  Feb 9, 2006
...identified molecular markers for increased virulence, and susceptibility to clindamycin and fluoroquinolones (levofloxacin, gatifloxacin, and moxifloxacin). ... - AAP Grand Rounds (subscription)

CAPRIE study: Moxifloxacin more effective in elders pneumonia  Jan 24, 2006
Treated with the newer medication, moxifloxacin HCI, 97.9 percent of hospitalized patients recovered within three to five days of therapy onset, compared to 90 ... - RxPG NEWS,

SA study cites drug's role  Jan 25, 2006
Doctors compared the effectiveness of moxifloxacin, a newer antibiotic sold under the brand name Avelox, with levofloxacin, or Levaquin, which has been the ... - San Antonio Express (subscription),

Newer Antibiotic more Effective at Treating Pneumonia in Senior ...  Jan 24, 2006
...cause of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed ... - SeniorJournal.com,

Head-To-Head Study Shows More Elderly Patients With Community ...  Jan 24, 2006
24 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at ... - PR Newswire (press release),

The University of Texas Study: Newer Antibiotic More Effective at ...  Jan 24, 2006
...time the two leading antibiotics for CAP have been compared in a well-controlled clinical trial." Treated with the newer medication, moxifloxacin HCI, 97.9 ... - PR Newswire (press release),

Researchers find improved treatment for pneumonia in elderly  Jan 24, 2006
The antibiotic moxifloxacin HCI has proved more effective in battling community-acquired pneumonia in patients 65 and older than levofloxacin, the antibiotic ... - San Antonio Business Journal,

Newer antibiotic battles pneumonia better  Jan 24, 2006
24 (UPI) -- Antibiotic moxifloxacin HCI is 8 percentage points more effective in curing elderly pneumonia than the other standard drug, levofloxacin ... - United Press International

Bayer Drug Better Than Leading Pneumonia Treatment  Jan 28, 2006
Significantly more elderly patients treated with the Bayer drug Avelox (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days three to ... - International News Service,

Head-To-Head Study Shows More Elderly Patients With Community ...  Jan 24, 2006
KENILWORTH, NJ, January 24, 2006 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired ... - PharmaLive.com (press release),

New combination treatment that could dramatically shorten the ...  Jan 10, 2006
...first two months of therapy and compared with standard WHO-recommended treatment and two other similar regimens which contained either ofloxacin or moxifloxacin ... - News-Medical.net,

(PRN) - Emerging Market for Omega-3 Fatty Acids Gains Ground ... ...  Jan 24, 2006
...(PRN) - Head-To-Head Study Shows More Elderly Patients With Community-Acquired Pneumonia Recovered at Days 3 to 5 With AVELOX(R) (Moxifloxacin HCl) Compared to ... - Bolsamania.com,

New Drug Combination May Shorten TB Treatment  Jan 17, 2006
...treat TB in four months. They say ethambutol could also be replaced with another drug, moxifloxacin. Further tests are planned to ... - Voice of America

E. Coli Defense Mechanism May Provide Key to Disrupting Bacteria ...  Jan 16, 2006
...cases of gastroenteritis, antibiotics such as erythromycin, clarithromycin, azithromycin ciprofloxacin, levofloxacin, gatifloxacin, or moxifloxacin may shorten ... - Newsinferno.com,

Shionogi Launches New Quinolone Antibacterial "Avelox(R) Tablet ...  Dec 9, 2005
...(TSE: 4507) today announced the Japan launch of "Avelox(R) Tablet 400mg (moxifloxacin hydrochloride), a new quinolone antibacterial licensed from Bayer Yakuhin ... - Japan Corporate News (press release),

Shionogi Launches New Quinolone Antibacterial “Avelox Tablet ...  Dec 9, 2005
...(Head Office: Osaka, President: Motozo Shiono) today announced the Japan launch of “Avelox® Tablet 400mg� (generic name: moxifloxacin hydrochloride), a ... - PharmaLive.com (press release),

Shionogi Launches New Quinolone Antibacterial Avelox(R) Tablet ...  Dec 9, 2005
09, 2005 - (JCN Newswire) - Shionogi & Co., Ltd. (TSE: 4507) today announced the Japan launch of "Avelox(R) Tablet 400mg (moxifloxacin hydrochloride), a new ... - Biotech Intelligence (press release),

FDA approves AVELOX (moxifloxacin HCl) for treatment of ...  Nov 29, 2005
SGP) today announced that the US Food and Drug Administration (FDA) has approved the once-daily, broad-spectrum antibiotic AVELOX® (moxifloxacin HCl) for a ... - EurekAlert (press release),

FDA Approves New Indication for Avelox (moxifloxacin HCl) for ...  Nov 30, 2005
...today announced that the US Food and Drug Administration (FDA) has approved the once-daily, broad-spectrum antibiotic Avelox(R) (moxifloxacin HCl) for a new ... - DG News

TB treatment and diagnostics pipeline: once empty, suddenly offers ...  Dec 2, 2005
...a partnership with Bayer Healthcare AG to conduct a clinical trial programme exploring the potential for an existing antibiotic, moxifloxacin, to shorten the ... - Aidsmap,

FDA Approvals: Avelox, Avandaryl, Trileptal  Dec 1, 2005
...maleate plus glimepiride tablets for first- and second-line use in the treatment of type 2 diabetes mellitus; a new indication for moxifloxacin HCl tablets and ... - Medscape (subscription)

New Epidemic Strain of C. difficile Seen Emerging in North America  Dec 2, 2005
...type. All of the current BI/NAP1 isolates, and none of the historic isolates, were resistant to gatifloxacin and moxifloxacin. "If ... - Medscape (subscription)

FDA has approved new indication for Avelox: treatment of ...  Dec 6, 2005
FDA ( US Food and Drug Administration ) has approved the once-daily, broad-spectrum antibiotic Avelox ( Moxifloxacin HCl ) for a new use -- the treatment of ... - Xagena.it,

Deadly Bacterial Illness May Be Spreading  Dec 1, 2005
What's more, that strain also seems to have built resistance to gatifloxacin and moxifloxacin, which are two of the newest in a class of antibiotics commonly ... - CBS News

New intestinal bug emerging in North America  Dec 2, 2005
The predominant strain was similar to that observed by McDonald's group and was resistant to ciprofloxacin, moxifloxacin, gatifloxacin and levofloxacin. ... - Reuters

Euronext Brussels) - Bayer : Avelox ® Approved in US to Treat ...  Nov 30, 2005
Leverkusen - Bayer HealthCare announced today that the FDA has approved its quinolone antibiotic Avelox® (moxifloxacin) for the treatment of complicated intra ... - Euronext,

(PRN) - Armor Holdings, Inc. Receives $20.2 Million Order for ...  Nov 30, 2005
...[+]. (PRN) - FDA Approves New Indication for AVELOX(R) (moxifloxacin HCl) for Treatment of Complicated Intra-Abdominal Infections (cIAI) ... [. ... - Bolsamania.com,

Deadly bacterial illness spreading  Dec 2, 2005
That strain also seems to have built resistance to two of the newest in a class of antibiotics used in hospitals - gatifloxacin and moxifloxacin. ... - myDNA.com,

Deadly Bacterial Illness May Be Spreading  Dec 2, 2005
What‘s more, that strain also seems to have built resistance to gatifloxacin and moxifloxacin, which are two of the newest in a class of antibiotics commonly ... - Herald News Daily,

Avelox approved for stomach problems  Dec 1, 2005
Corporation announced that the US Food and Drug Administration (FDA) has approved the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) for a new ... - myDNA.com,

CDC: Deadly bacterial illness appears to be spreading  Dec 1, 2005
What's more, the BI strain - as it is called - also seems to have built resistance to gatifloxacin and moxifloxacin, which are two of the newest in the ... - Kansas City Star,

When public health outweighs profits  Nov 10, 2005
At the same time Roche was in the news, Bayer was making quieter news by announcing that it will donate its antibiotic moxifloxacin — known as Avelox — for ... - USA Today

Big firms join drug program  Nov 15, 2005
Last month, Bayer agreed to donate one of its existing antibiotics, moxifloxacin, to the nonprofit TB Alliance, which will back clinical testing of the drug to ... - New York Daily News,

Experts promote earlier use of more potent antibiotics for ...  Sep 20, 2005
...reviewed the existing treatment guidelines for these infections and also summarised new data from recent clinical trials of moxifloxacin (Avelox ® ), Bayer ... - PharmaLive.com (press release),

Legionnaires' disease - Legionellosis  Oct 6, 2005
The current treatment of choice are the respiratory tract quinolones (levofloxacin, moxifloxacin, gemifloxacin) or newer macrolides (azithromycin ... - Food Consumer,

Many meds don't mix with the sun  Sep 21, 2005
Gris-PEG), isoniazid (Nydrazid), levofloxacin (Levaquin), lomefloxacin (Maxaquin), metronidazole (Flagyl), minocycline (Minocin), moxifloxacin (Ave-lox ... - Pioneer Press,

Ortho-McNeil: less is more with Levaquin  Aug 9, 2005
...fluoroquinolones most commonly used for patients with moderate ABS and prior exposure to antibiotics, namely Bayer's [BAY.F] Avelox (moxifloxacin) and Bristol ... - Pharmaceutical Business Review

FDA Approvals: Rozerem, Synera, Avelox IV  Jul 28, 2005
70-mg/70-mg topical patch to provide local dermal analgesia for superficial venous access and dermatologic procedures; and moxifloxacin intravenous infusion ... - Medscape (subscription)

International Approvals: Avalox IV, Pegasys, Influvac  Jul 25, 2005
July 25, 2005 — The European Commission has approved moxifloxacin HCl intravenous infusion for the treatment of complicated skin and skin structure infections ... - Medscape (subscription)

Avelox® IV Approved in Europe to Treat Complicated Skin and Skin ...  Jul 30, 2005
Bayer HealthCare announced that Avelox® IV (moxifloxacin HCl, solution for Infusion) was approved for the treatment of complicated Skin and Skin Structure ... - I-Newswire.com (press release)

FDA Bans Poultry Antibiotic to Prevent Resistant Human Infections  Jul 29, 2005
...class. Common human agents in this class include Cipro (ciprofloxacin), Avelox (moxifloxacin), and Levaquin (levofloxacin). The ... - MedPage Today

Avelox IV Approved in Europe to Treat Complicated Skin and Skin ...  Jul 18, 2005
LEVERKUSEN, Germany, July 18, 2005 – Bayer HealthCare today announced that Avelox® IV (moxifloxacin HCl, solution for Infusion) was approved for the ... - PharmaLive.com (press release)

Drug-drug interaction studies have not been conducted with VIGAMOX™ solution. In vitro studies indicate that moxifloxacin does not inhibit CYP3A4, CYP2D6, CYP2C9, CYP2C19, or CYP1A2 indicating that moxifloxacin is unlikely to alter the pharmacokinetics of drugs metabolized by these cytochrome P450 isozymes.